Quick answer
What is Somatostatin?
Built from index records dated 2026-10-09 to 2026-10-13 Compiled by an automated pipeline, checked by The Peptide Observer editorial desk How this site works
Somatostatin is a peptide, grouped on this site under Endocrine and immune signalling peptides, and the 12 research records kept here are 8 from studies in rats or mice and 4 that do not state what kind of study it is.
The literature search returned 37,235 records. This site keeps 12 of them, which is 0.03 per cent of what came back.
What it is
This site puts it in the Endocrine and immune signalling peptides group.
The endogenous ligand of the five somatostatin receptor subtypes, per the retrieved receptor-family review, acting as an inhibitory hormone on growth hormone and gut secretion.[1, 2]
Stated in the titles of the cited 1999 Frontiers in Neuroendocrinology and 1983 New England Journal of Medicine papers.
What kind of records
The records kept here are animal and laboratory studies only.
That sentence is produced by counting, not by reading. What was counted: no interventional human trial record; 8 rodent and 0 in vitro records among 12.
What this does not settle
- What it does in a body. Counting records is not reading them, and nothing here has been read in full.
- Whether it causes harm. No adverse-effect row was taken from any source for this entry.
- How long it lasts. No pharmacokinetics source was retrieved for this entry.
- What the other 37,223 retrieved records say. They are not in this index.
The longer explanation
Where this comes from
The records cited above, in full.
- Somatostatin and its receptor family. Frontiers in neuroendocrinology (1999). pmid:10433861
- Somatostatin. The New England journal of medicine (1983). pmid:6139753